Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-20-005226
Filing Date
2020-06-12
Accepted
2020-06-12 09:04:20
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27626
2 filename2.txt TEXT-EXTRACT 1433
  Complete submission text file 0000000000-20-005226.txt   40144
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filed for) CIK: 0001426332 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations